Drug
Ac01
Ac01: highest development phase Phase 2, developed by AnaCardio AB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AnaCardio AB
Trials
| Drug | Phase | Indication |
|---|---|---|
| AC01 NCT07584967 | Phase 2 | Heart Failure With Reduced Ejection Fraction (HFrEF) |
Latest
No recent events.
Follow Ac01 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.